Cdkn2c-KO Mouse
一般名
Cdkn2c-KO
製品ID
S-KO-01471
背景情報
C57BL/6JCya
系統ID
KOCMP-12580-Cdkn2c-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Cdkn2c-KO Mouse（カタログ番号S-KO-01471）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Cdkn2c-KO
系統ID
KOCMP-12580-Cdkn2c-B6J-VA
遺伝子名
製品ID
S-KO-01471
遺伝子別名
p18, INK4c, p18-INK6, p18INK4c, p18-INK4c
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 4
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000097921
NCBIトランスクリプトID
NM_001301368
ターゲット領域
Exon 3
有効領域の大きさ
~2.3 kb
遺伝子研究の概要
Cdkn2c, also known as p18INK4C, is a cell growth regulator that controls cell cycle progression by inhibiting cyclin-dependent kinases. It is involved in multiple pathways related to metabolism, cancer development, and cell differentiation, and thus is of great biological importance. Genetic models, such as gene knockout mouse models, can be used to study its function [1,2,3,4,5,6,7,8].
In adipose tissue, Cdkn2c mRNA expression is reduced in type II diabetes and obese subjects. Knockdown of Cdkn2c in human preadipocytes led to lower expression of differentiation markers and transiently reduced lipid accumulation during adipocyte differentiation, suggesting its role in adipose lipid storage [1]. In sporadic medullary thyroid carcinoma, loss of Cdkn2c is associated with worse M stage, overall AJCC stage, and decreased overall survival, especially when combined with RETM918T mutation [2]. In leiomyosarcoma, CDKN2C-null tumors represent a genomically distinct class with unique genetic alterations, rare TP53, RB1, and ATRX mutations, and frequent CIC genomic alterations and 1p/19q-codeletion [3]. In gastric cancer, c-Myc and PRMT5 interact to transcriptionally repress Cdkn2c expression to promote cell growth [4]. In lung adenocarcinoma, CBX8 promotes tumor growth and metastasis by transcriptionally repressing Cdkn2c [5]. In multiple myeloma, deletions of Cdkn2c are associated with worse overall survival, and cases with homozygous deletions are the most proliferative [8].
In conclusion, Cdkn2c plays essential roles in cell cycle regulation, adipocyte differentiation, lipid storage, and is implicated in various diseases like diabetes, multiple types of cancer. Gene knockout or knockdown models have been crucial in revealing these functions, providing insights into disease mechanisms and potential therapeutic targets in these disease areas.
References:
1. Pereira, Maria J, Vranic, Milica, Kamble, Prasad G, Hetty, Susanne, Eriksson, Jan W. 2021. CDKN2C expression in adipose tissue is reduced in type II diabetes and central obesity: impact on adipocyte differentiation and lipid storage? In Translational research : the journal of laboratory and clinical medicine, 242, 105-121. doi:10.1016/j.trsl.2021.12.003. https://pubmed.ncbi.nlm.nih.gov/34896253/
2. Grubbs, Elizabeth G, Williams, Michelle D, Scheet, Paul, Cabanillas, Maria E, Cote, Gilbert J. 2016. Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma. In Thyroid : official journal of the American Thyroid Association, 26, 1553-1562. doi:. https://pubmed.ncbi.nlm.nih.gov/27610696/
3. Williams, Erik A, Sharaf, Radwa, Decker, Brennan, Ramkissoon, Shakti H, Elvin, Julia A. 2020. CDKN2C-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53/RB1-Wild-Type Tumor With Frequent CIC Genomic Alterations and 1p/19q-Codeletion. In JCO precision oncology, 4, . doi:10.1200/PO.20.00040. https://pubmed.ncbi.nlm.nih.gov/33015533/
4. Liu, Ming, Yao, Bing, Gui, Tao, Ju, Junyi, Zhao, Quan. 2020. PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression. In Theranostics, 10, 4437-4452. doi:10.7150/thno.42047. https://pubmed.ncbi.nlm.nih.gov/32292506/
5. Chen, Hao, Su, Yijie, Yang, Lihong, Liu, Min, Xuan, Chenghao. 2023. CBX8 promotes lung adenocarcinoma growth and metastasis through transcriptional repression of CDKN2C and SCEL. In Journal of cellular physiology, 238, 2710-2723. doi:10.1002/jcp.31124. https://pubmed.ncbi.nlm.nih.gov/37733753/
6. El Naofal, Maha, Kim, Adriel, Yon, Hui Yi, Cote, Gilbert J, Hu, Peter. . Role of CDKN2C Fluorescence In Situ Hybridization in the Management of Medullary Thyroid Carcinoma. In Annals of clinical and laboratory science, 47, 523-528. doi:. https://pubmed.ncbi.nlm.nih.gov/29066476/
7. Eller, Carla, Heydmann, Laura, Colpitts, Che C, Verrier, Eloi R, Baumert, Thomas F. 2020. A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor. In Nature communications, 11, 2707. doi:10.1038/s41467-020-16517-w. https://pubmed.ncbi.nlm.nih.gov/32483149/
8. Leone, Paola E, Walker, Brian A, Jenner, Matthew W, Davies, Faith E, Morgan, Gareth J. . Deletions of CDKN2C in multiple myeloma: biological and clinical implications. In Clinical cancer research : an official journal of the American Association for Cancer Research, 14, 6033-41. doi:10.1158/1078-0432.CCR-08-0347. https://pubmed.ncbi.nlm.nih.gov/18829482/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。